All Posts Tagged With: "Vytorin"
Profits Before People: Merck and Schering-Plough Caught Red handed
Emails between a Schering-Plough executive and the principle investigator of the ENHANCE trial were made public today by Sen. Chuck Grassley. The emails reveal that the ENHANCE trial’s principal investigator perceived that the drugmakers were withholding unfavorable results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons. (Surprise Surprise). Instead of releasing the bad data, Sen. Grassley noted, [...]
Popularity: 64% [?]
1Apr2008 | PharmaWatchDog | 0 comments | Continued
Merck and Schering-Plough Continue to Feel the Heat
A House committee implied today that Merck and Schering-Plough were aware months before they issued preliminary results of the ENHANCE study in a press release that the trial was negative.
The committee made public several anonymous emails posted on an industry chat site suggesting knowledge up to nine months before release of the preliminary data [...]
Popularity: 53% [?]
15Feb2008 | PharmaWatchDog | 1 comment | Continued
